Pyrogen Testing Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Pyrogen Testing 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  l a t es t  r epo r t  by  IMARC G roup ,  t i t l ed  "Pyrogen Test i ng  Market :  
G loba l  I ndust ry  T rends ,  Share ,  S ize ,  Grow th ,  Opportun i ty  and  Forecast  2024-
2032, "  t he  g loba l  py rogen  t es t ing  m arke t  s i ze  reached US$  1 .4  B i l l i on  in  2023 .
Report Pyrogen re fe rs  to  a  subs tance w ide ly  de r i ved  f r om fung i ,  bac t e r ia  and  v i r uses  tha t  induces  a  r i se  in  t empera t u re  in  an  an ima l  o r  hum an  v ia  the  s t imu la t ion  o f  
t he  inna t e  immune  sys t em.  Py rogen  tes t ing  i s  a  me thod  t ha t  i s  genera l l y  adop ted  
Highlight and f o r  ensu r i ng  t he  sa fe ty  o f  med ica l  dev ices  and  pharmaceu t i ca l  p roduc ts .  
I t  i s  an  essen t ia l  t es t  f o r  avo id ing  l i f e - th rea t en ing  feve r  reac t ions  caused  by  
Description py rogen ic  subs tances ,  such  as  non-endo tox in  and endo tox in  py rogens .  The presence  o f  we l l -es t ab l i shed  hea l t hca re  in f r as t ruc tu res  ac ross  mu l t ip l e  coun t r ies  
i s  f avorab ly  im pac t ing  the  marke t .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/py rogen- t es t ing -marke t / r eques tsam ple
Report Description
G lo b a l  P y r o g e n  T e s t i n g  M a r k e t  T r e n d s :
T h e  g l o b a l  m a r k e t  i s  p r i m a r i l y  d r i v e n  b y  t h e  g r o w i n g  n e e d  f o r  i n f e c t i o n - f r e e  m e d i c a l  p r o d u c t s .  C o u p l e d  w i t h  t h e  i n c r e a s i n g  
i n c i d e n c e s  o f  i n f e c t i o u s  d i s e a s e s  c a u s e d  b y  m i c r o o r g a n i s m s  a m o n g  t h e  m a s s e s ,  t h i s  h a s  e n c o u r a g e d  l e a d i n g  p l a y e r s  t o  h e a v i l y  
i n v e s t  i n  t h e  a d o p t i o n  o f  p y r o g e n  t e s t i n g  t o o l s  f o r  d e v e l o p i n g  s a f e  m e d i c a l  p r o d u c t s  a n d  e n s u r i n g  t h e  a b s e n c e  o f  t o x i c  m o l e c u l a r  
p r o d u c t s .  I n  a d d i t i o n  t o  t h i s ,  t h e  r a p i d  o u tb r e a k  o f  c o r o n a v i r u s  d i s e a s e  ( C O V I D - 1 9 )  h a s  p r o p e l l e d  t h e  m a r k e t  g r o w t h .  
M o r e o v e r ,  t h e  r i s i n g  f u n d i n g  f o r  c o n d u c t i n g  e x te n s i v e  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  i n  l i f e  s c i e n c e s  a r e  f u r t h e r  
p r o v i d i n g  a  b o o s t  t o  t h e  d e m a n d  f o r  p y r o g e n  t e s t i n g  a c r o s s  t h e  g l o b e .  A d d i t i o n a l l y ,  c o n t i n u a l  t e c h n o l o g i c a l  a d v a n c e m e n ts  a n d  t h e  
i n t r o d u c t i o n  o f  a d v a n c e d  t e s t i n g  e q u i p me n t  a r e  a c t i n g  a s  m a j o r  g r o w t h - i n d u c i n g  f a c to r s .  A l o n g  w i t h  t h i s ,  c o n t i n u o u s  i mp r o v e m e n ts  
i n  b i o t e c h n o l o g y  a n d  p h a r m a c e u t i c a l  i n f r a s t r u c tu r e  a r e  c r e a t i n g  a  p o s i t i v e  m a r k e t  o u t l o o k .  O th e r  f a c t o r s ,  i n c l u d i n g  t h e  e s c a l a t i n g  
p r e v a l e n c e  o f  c h r o n i c  d i s o r d e r s  a n d  s e v e r a l  i n i t i a t i v e s  u n d e r t a k e n  b y  t h e  g o v e r n m e n t  o f  m u l t i p l e  c o u n t r i e s  f o r  d e v e l o p i n g  
r e g u l a to r y  f r a m e w o r k s ,  a r e  a l s o  p o s i t i v e l y  i n f l u e n c i n g  t h e  m a r k e t  d e m a n d .
L o o k in g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c ip a t e d  t o  r e a c h  a  v a lu e  o f  U S $  3 .1  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  C A G R  o f  9 . 2 %  d u r in g  
2 0 2 4 - 2 0 3 2 .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / p y r o g e n - t e s t i n g - m a r k e t
Breakup by Product:
• Instruments
• Kits and Reagents
• Services
 
Breakup by Test Type:
Report • In-vitro Tests
Segmentation • LAL Tests
• Rabbit  Tests
• Others
Breakup by Application:
• Pharmaceut ical  and Biologics
• Medical  Devices
• Others
Breakup by Region:
• North America
Report • Asia-Pacifi c
• Europe
Segmentation
• Latin America
• Middle East and Afr ica
• Charles River Laboratories International Inc.
• Ellab A/S
• Fujifi lm Wako Pure Chemical Corporation 
(Fujifi lm Holdings Corporation)
Competitive • Lonza Group AG
• Merck KGaA
Landscape • Microcoat Biotechnologie GmbH
with Key • Nelson Laboratories LLC (Sotera Health)
Players • North American Science Associates Inc.
• Pacifi c Biolabs Inc.
• Sanquin Reagents BV
• Thermo Fisher Scientifi c Inc
• Toxikon Corporation
• Wuxi Apptec.
How has the global pyrogen testing market 
performed so far, and how will it perform in the 
coming years?
What are the drivers, restraints, and opportunities 
in the global pyrogen testing market?
Key What is the impact of each driver, restraint, and 
opportunity on the global pyrogen testing market?
Questions 
Answered in What are the key regional markets?
the Report
Which countries represent the most attractive 
pyrogen testing market?
What is the breakup of the market based on the 
product?
Which is the most attractive product in the pyrogen 
testing market?
What is the breakup of the market based on the 
test type?
Which is the most attractive test type in the 
pyrogen testing market?
Key What is the breakup of the market based on the 
application?
Questions 
Answered in Which is the most attractive application in the pyrogen testing market?
the Report
What is the competitive structure of the market?
Who are the key players/companies in the global 
pyrogen testing market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  P y r o g e n  T e s t i n g  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     I n s t r u m e n t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     K i t s  a n d  R e a g e n t s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     S e r v i c e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T e s t  T y p e
       
    7 . 1     I n - v i t r o  T e s t s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     L A L  T e s t s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     R a b b i t  T e s t s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     O t h e r s
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
Table of 8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     P h a r m a c e u t i c a l  a n d  B i o l o g i c s
        8 . 1 . 1  M a r k e t  T r e n d s
Contents         8 . 1 . 2  M a r k e t  F o r e c a s t    8 . 2     M e d i c a l  D e v i c e s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     O t h e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  R e g i o n
    9 . 1     N o r t h  A m e r i c a
        9 . 1 . 1  U n i t e d  S t a t e s
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t
        9 . 1 . 2  C a n a d a
           9 . 1 . 2 . 1  M a r k e t  T r e n d s
           9 . 1 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / p y ro ge n - t e s t i n g - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: